Henry Meds Review: Current Plan Terms and Care Questions
Henry’s current weight-management page describes a prescription-dependent subscription with provider visits, medication, supplies and support. Its published starting price and fulfillment terms differ from older comparison tables. Confirm the exact treatment and payment obligation before enrolling.
Current scope and process
Henry’s current page describes clinical review and delivery if prescribed. Its broader homepage also lists phentermine, testosterone, women’s hormone care and erectile-dysfunction services, so it is inaccurate to describe the business as GLP-1-only or certify tirzepatide as its exclusive specialty.
Price and multi-month obligations
On October 27, 2026, the public GLP-1 page advertised starts at $179 monthly, including provider visits, medication, supplies and ongoing support. It says plan and dose affect cost. Ask for the selected plan’s full price and any separately billed nutrition services. Current plan description. For broader online weight-management care, SurpassMD describes its program and assessment process.
The site permits cancellation through its portal or support, but says a multi-month-plan balance may remain payable unless a provider determines a medical reason prevents continuation. Cancel-anytime should not be read as every future payment disappearing.
Dispatch is not delivery
The current page says most patients receive medication 8–10 business days after speaking to a provider, with 45-day injectable or 90-day oral shipments as prescribed and possible California delays. These are company estimates, not a fulfillment test. Confirm the actual formulation, supply and next refill before transferring care.
Clinical access and coaching scope
Ask how to reach the prescribing clinician, what follow-up is included, which services require appointments and what happens between shipments. The reviewed sources do not establish 30–45 minute consultations, a registered-dietitian package or objectively better assessment than competitors. Routine messaging is not emergency care.
Outcomes and approval are separate
The company cites a retrospective compounded-semaglutide cohort and reports approximately 18% one-year weight loss. That is a provider-attributed observational claim, not evidence that every compounded preparation equals an approved product. The original paper was not accessible in this source check, so its completeness and selection effects remain unadjudicated. Provider citation and claim. The distinction between a research compound and a medicine is covered in our guide to FDA approval.
FDA’s current guidance distinguishes compounded medicines from approved drugs. A broad clean-warning-letter claim is not a substitute for a defined current search or product assessment; this review establishes no company-wide absence of enforcement history.
What to compare before choosing
Use the written price at the prescribed dose, payment commitment, pharmacy identity, refill schedule, clinical access and cancellation obligation. No independent evidence here ranks Henry’s care, service reliability or safety above or below Ro, Hims, Found, Calibrate or other providers. When reviewing quotes, our GLP-1 Price Check directory can help organize upfront and ongoing program costs.